With recent court rulings in the US against Prometheus Laboratories and Myriad Genetics, rules issued by the Patent and Trademark Office say that for an invention to be patentable it has to be "significantly different" from natural products.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.